The whistleblower pharmaceutical sales reps in the Procrit case reinstated in a Massachussetts federal court claim that their careers at Johnson & Johnson's Ortho Biotech unit were based mostly on ...
Dear Dr. Roach: I am a patient with myelofibrosis, and have been under treatment for over three years. At one time I was receiving blood transfusions every three weeks and taking Jakafi (very ...
Johnson & Johnson is trimming its sales force for anemia drug Procrit, a top-seller that has lost market share recently due to increased competition from Amgen’s Aranesp. Ortho Biotech Products, the J ...
Johnson & Johnson said some of its Procrit anemia treatment was found diluted to greatly reduce the amount of active medicine in the solution, the latest in a string of drug counterfeiting incidents ...
DEAR DR. ROACH: I am a patient with myelofibrosis, and have been under treatment for over three years. At one time I was receiving blood transfusions every three weeks and taking Jakafi (very ...
(CN) - The Supreme Court on Monday refused to block a lawsuit against a Johnson & Johnson subsidiary by salesmen who accused the company of giving kickbacks to doctors for prescribing its anemia drug ...
Amgen and Centocor Ortho Biotech announced a voluntary nationwide recall of certain lots of Epogen (epoetin alfa) and Procrit (epoetin alfa) vials that may contain extremely thin glass flakes ...
NEW YORK – Johnson & Johnson (JNJ) has sued Amgen (AMGN), accusing the world's largest biotechnology company of hampering sales of J&J's anemia drug, Procrit (search), by using anti-competitive ...
Epoetin alfa 10000 Units, 20000 Units; per mL; soln for IV or SC inj; contains albumin (human) and benzyl alcohol. Individualize (see full labeling for titration). CKD: initially 50–100 Units/kg 3 ...
Dec. 2, 2005 -- The US Food and Drug Administration (FDA), Amgen Inc, and Ortho Biotech Clinical Affairs, LLC, have notified healthcare professionals via letter regarding revisions to the safety ...
Products were found to contain thin glass flakes, but their potential to impact patients is expected to be low. Amgen has voluntarily recalled certain lots of Epogen® and Procrit® (epoetin alfa) vials ...